Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
---|
04/05/1995 | EP0646649A1 Method of producing iturin A and antifungal agent for profund mycosis |
04/05/1995 | EP0646648A1 Method for producing polypeptide |
04/05/1995 | EP0646646A2 Protein expression system |
04/05/1995 | EP0646645A2 A process for producing a substance |
04/05/1995 | EP0646644A2 Periplasmic membrane-bound system for detecting protein-protein interactions |
04/05/1995 | EP0646600A1 A cell growth-inhibiting protein |
04/05/1995 | EP0646378A1 Agent for enhancing the yield of antibodies in immunology |
04/05/1995 | EP0646244A1 Immunoassay and test kit for thrombin-antithrombin iii complex |
04/05/1995 | EP0646175A1 RECOMBINANT $i(PSEUDOMONAS) EXOTOXIN WITH INCREASED ACTIVITY |
04/05/1995 | EP0646174A1 Recombinant production of saporin-containing proteins |
04/05/1995 | EP0646173A1 Reagent for agglutination assays |
04/05/1995 | EP0646170A1 DIABETOGENE $i(rad): A TYPE II DIABETES SPECIFIC GENE |
04/05/1995 | EP0646132A1 Amino sugars, glycoproteins, method of preparing them, medicines containing them and their use |
04/05/1995 | EP0646129A1 Receptor-type tyrosine kinase-like molecules |
04/05/1995 | EP0646015A1 Contraceptive vaccine |
04/05/1995 | EP0646013A1 Platelet derived growth factor antagonists |
04/05/1995 | EP0549675B1 Detergent containing protease and inhibitor and novel inhibitors for use therein |
04/05/1995 | EP0513161B1 Immune reactivity to expressed activated oncogenes for diagnosis and treatment of malignancy |
04/05/1995 | EP0507839B1 Method of separating haemopoietic progenitor cells |
04/05/1995 | EP0318554B1 Targeted multifunctional proteins |
04/05/1995 | EP0277212B1 Diagnostic assay for inhibitor of tissue-type and urokinase-type plasminogen activators, and gene coding for the inhibitor |
04/05/1995 | EP0180615B1 Novel atrial natriuretic/vasodilator polypeptides |
04/05/1995 | CN1028114C Monoclonal antibody specific for adhesion function domain of phagocyte surface protein |
04/05/1995 | CA2133355A1 Method for producing polypeptide |
04/04/1995 | US5403924 Taga gene and methods for detecting predisposition to peptic ulceration |
04/04/1995 | US5403915 Isolation and purification of lung surfactant protein |
04/04/1995 | US5403737 Serine protease variants having peptide ligase activity |
04/04/1995 | US5403734 t-PA with growth factor domain substitutions |
04/04/1995 | US5403718 Methods and antibodies for the immune capture and detection of Borrelia burgdorferi |
04/04/1995 | US5403713 Administering detectable amount of labeled anti-elam-1 monoclonal antibody and detecting the label |
04/04/1995 | US5403581 Administering immunogenic polypeptide to poultry |
04/04/1995 | CA1335083C Fr901228 substance and preparation thereof |
04/03/1995 | EP0672152A4 Fusion proteins comprising mgf and il-3. |
03/31/1995 | CA2132937A1 Protein expression system |
03/30/1995 | WO1995008646A1 Prenatal diagnosis by isolation of fetal granulocytes from maternal blood |
03/30/1995 | WO1995008632A1 Immunoreactive antigens of hepatitis e virus |
03/30/1995 | WO1995008631A2 Target antigens of transmission blocking antibodies for malaria parasites |
03/30/1995 | WO1995008630A1 Surface loop structural analogues of fibroblast growth factors |
03/30/1995 | WO1995008629A1 Receptor recognition factors, protein sequences and methods of use thereof |
03/30/1995 | WO1995008628A2 Nucleic acids encoding merosin, merosin fragments and uses thereof |
03/30/1995 | WO1995008627A1 Human metabotropic glutamate receptor subtypes (hmr4, hmr6, hmr7) and related dna compounds |
03/30/1995 | WO1995008576A1 Monoclonal antibodies against leukocyte-specific g-protein-coupled receptors |
03/30/1995 | WO1995008570A1 Chimeric proteins which block complement activation |
03/30/1995 | WO1995008554A1 Nf-at polypeptides and polynucleotides |
03/30/1995 | WO1995008343A1 Modified truncated complement system regulators |
03/30/1995 | WO1995005452A3 Improved compositions and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules |
03/30/1995 | CA2172610A1 Chimeric proteins which block complement activation |
03/30/1995 | CA2172504A1 Prenatal diagnosis by isolation of fetal granulocytes from maternal blood |
03/30/1995 | CA2172490A1 Receptor recognition factors, protein sequences and methods of use thereof |
03/30/1995 | CA2172385A1 Nucleic acids encoding merosin, merosin fragments and uses thereof |
03/30/1995 | CA2172287A1 Nf-at polypeptides and polynucleotides |
03/30/1995 | CA2171206A1 Human metabotropic glutamate receptor subtypes (hmr4, hmr6, hmr7) and related dna compounds |
03/30/1995 | CA2170521A1 Immunoreactive antigens of hepatitis e virus |
03/29/1995 | EP0645451A1 Heparin binding site structural analogues of fibroblast growth factors |
03/29/1995 | EP0645450A1 Human calcitonin precursor polyprotein structural gene |
03/29/1995 | EP0644948A1 Anti-receptor antibodies to the vitamin b12/transcobalamin ii receptor |
03/29/1995 | EP0644947A1 Anti-idiotypic monoclonal antibodies against the lewis y-specific monoclonal antibody br55-2 and their uses |
03/29/1995 | EP0644938A1 PRODUCTION OF STREPTAVIDIN FROM $i(BACILLUS SUBTILIS) |
03/29/1995 | EP0644937A1 Therapeutic and diagnostic methods based on neurotrophin-4 expression |
03/29/1995 | EP0644936A1 Chimeric receptor polypeptides, human h13 proteins and uses thereof |
03/29/1995 | EP0644935A1 DNA SEQUENCES ENCODING THE HUMAN A1, A2a and A2b ADENOSINE RECEPTORS |
03/29/1995 | EP0644930A1 Monoclonal antibody against the extra-villous trophoblast |
03/29/1995 | EP0644900A1 A monoclonal antibody to a human mdr1 multidrug resistance gene product, and uses |
03/29/1995 | EP0644899A1 Production of recombinant human lactoferrin |
03/29/1995 | EP0644889A1 COMPOSITIONS AND METHODS FOR MODULATING $g(b)-AMYLOID |
03/29/1995 | EP0644774A1 Improved production of reproductive hormones |
03/29/1995 | EP0563144B1 Diagnosis for porcine malignant hyperthermia |
03/29/1995 | EP0460190B1 Method for detecting malignant diseases |
03/29/1995 | EP0393045B1 Fv antibody fragment production |
03/29/1995 | EP0374162B1 Balanced constitutive inducible transcription system |
03/29/1995 | EP0332667B1 Vector for integration site independent gene expression in mammalian host cells |
03/29/1995 | CN1100757A Novel plasmid for production of CRM protein and diphtheria toxin |
03/28/1995 | US5401828 Mutant genes present in malignant tumors, detection, tumor specific antibodies for treatment |
03/28/1995 | US5401721 Antiulcer agents and antisecretory agents |
03/28/1995 | US5401651 DNA encoding ENA-78, a neutrophil activating factor |
03/28/1995 | US5401643 Method of preparing an active human neutrophil chemotactic factor polypeptide |
03/28/1995 | US5401641 Haptans for immune response and isolation |
03/28/1995 | US5401635 Nucleic acids encoding human prohibitin mutants and detection thereof |
03/28/1995 | US5401627 Warts, cancer |
03/28/1995 | CA2012631C Process for the production of hetero-bispecific antibodies |
03/28/1995 | CA1334944C Signal peptide, dna sequences coding for the latter, expression vectors carrying one of these sequences, gram-negative bacteria transformed by these vectors, and process for the periplasmic production of a polypeptide |
03/28/1995 | CA1334943C Leader sequence for the production of recombinant proteins |
03/28/1995 | CA1334942C Production of m-csf |
03/28/1995 | CA1334941C Cloning and expression of a host-protective immunogens of ibdv |
03/28/1995 | CA1334940C Production of glucose oxidase in recombinant systems |
03/25/1995 | CA2132668A1 Heparin binding site structural analogues of fibroblast growth factors |
03/23/1995 | WO1995008115A1 A method of assaying collagen fragments in body fluids, a test kit and means for carrying out the method and use of the method to diagnose the presence of disorders associated with the metabolism of collagen |
03/23/1995 | WO1995007994A2 Recombinant alphavirus vectors |
03/23/1995 | WO1995007992A2 Cloned glutamic acid decarboxylase |
03/23/1995 | WO1995007987A2 Novel proteins/polypeptides and cotransfection plasmids and live recombinant carriers therefor |
03/23/1995 | WO1995007986A1 Pharmaceutical compositions containing ecotin and homologs thereof |
03/23/1995 | WO1995007984A1 Human receptor h4-1bb |
03/23/1995 | WO1995007983A1 Human mu opioid receptor |
03/23/1995 | WO1995007982A1 Activin receptors-like kinase (alk), belonging to the tgf receptor family and/or to the bmp receptor family |
03/23/1995 | WO1995007978A1 A secretion sequence for the production of a heterologous protein in yeast |
03/23/1995 | WO1995007934A2 Il8 inhibitors |
03/23/1995 | WO1995007933A1 Methods and composition for the modulation of host immune response to allergens |
03/23/1995 | WO1995007931A1 Acylated insulin |
03/23/1995 | WO1995007922A1 Drug binding protein |
03/23/1995 | WO1995007907A1 Nucleoside derivatives, methods for the manufacture thereof and specific polyclonal and monoclonal antibodies of said derivatives |